Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06732921 · ClinicalTrials.gov registry record · NA
Recovery Control Tower Feasibility Pilot
A NA study of Elective Surgery, sponsored by Washington University School of Medicine.
- Active
- Registry status
- NA
- Development phase
- 8,500
- Enrollment target
- 1
- Study location
NCT06732921: Active NA study of Elective Surgery, sponsored by Washington University School of Medicine.
NCT06732921 is a NA study of Elective Surgery that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 8,500 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (506% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06732921, a NA study of Elective Surgery, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 8,500 participants
- Enrollment target
- 1
- Study location
Study Summary
A pilot study in perioperative telemedicine that aims to demonstrate the efficiency, and safety of integrating telemedicine into the PACU environment. This pilot study will expand on our previously conducted proof-of-concept study for a telemedicine solution in the PACU. If this pilot study proves to be successful, the study team intends subsequently to expand such a telemedicine solution to multiple clinical locations.
Primary Outcome
Time patient enters PACU to time patient leaves PACU
Conditions Studied
Interventions
- DEVICE Alertwatch - Recovery Control Tower
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,500 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the registry record for NCT06732921 still lists
NCT06732921 is an interventional study that assigns participants to a tested intervention. Its 8,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (506% higher).
The record links to 1 condition, with Elective Surgery appearing as the primary indexed condition, and to 1 intervention - of which Alertwatch - Recovery Control Tower is the first listed.
NCT06732921 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06732921 about?
NCT06732921 is a clinical study titled "Recovery Control Tower Feasibility Pilot". A pilot study in perioperative telemedicine that aims to demonstrate the efficiency, and safety of integrating telemedicine into the PACU environment. This pilot study will expand on our previously conducted proof-of-concept study for a telemedicine solution in the PACU. If this pilot study proves t...
What is the current status of trial NCT06732921?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 8,500 participants. The study started on 2023-10-02. Estimated completion is 2025-09-30.
What conditions does trial NCT06732921 study?
This clinical trial studies the following conditions: Elective Surgery.
What interventions are being tested in trial NCT06732921?
The interventions under investigation include: Alertwatch - Recovery Control Tower (DEVICE).
Who is sponsoring clinical trial NCT06732921?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06732921 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Elective Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06732921's enrollment target sits among peer trials
8,500 18th of 2000 higher than 1,983 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- NCT07185828 · 8,286 participants · NA
Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI